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A B S T R A C T
Many studies have reported that heavy substance use is associated with impaired response inhibition. Studies
typically focused on associations with a single substance, while polysubstance use is common. Further, most
studies compared heavy users with light/non-users, though substance use occurs along a continuum. The current
mega-analysis accounted for these issues by aggregating individual data from 43 studies (3610 adult partici-
pants) that used the Go/No-Go (GNG) or Stop-signal task (SST) to assess inhibition among mostly “recreational”
substance users (i.e., the rate of substance use disorders was low). Main and interaction effects of substance use,
demographics, and task-characteristics were entered in a linear mixed model. Contrary to many studies and
reviews in the field, we found that only lifetime cannabis use was associated with impaired response inhibition in
the SST. An interaction effect was also observed: the relationship between tobacco use and response inhibition
(in the SST) differed between cannabis users and non-users, with a negative association between tobacco use and
inhibition in the cannabis non-users. In addition, participants’ age, education level, and some task characteristics
influenced inhibition outcomes. Overall, we found limited support for impaired inhibition among substance
users when controlling for demographics and task-characteristics.
1. Introduction
1.1. Substance use and response inhibition
1.1.1. What is response inhibition and how does it relate to substance use?
Inhibitory control, also known as response inhibition, has been
defined as the ability to control one’s attention, behavior, thoughts,
and/or emotions to override a strong internal predisposition or external
lure, and instead do what is more appropriate or needed (Diamond,
2013). Loss of control over one’s behavior is a defining characteristic of
addiction. The DSM-5 lists characteristics such as ‘taking larger
amounts or over a longer period than was intended’ and ‘unsuccessful
efforts to cut down or control alcohol use’ to define the loss of control
over drinking (American Psychiatric Association, 2013). Moreover, in-
hibitory control has been proposed to play an important role at dif-
ferent stages of the addiction cycle, i.e., 1) initial use of substance; 2)
transition from recreational use to heavier use and abuse; 3) con-
tinuation of use for those who get addicted; 4) relapse after abstinence
(e.g., Garavan et al., 2015; Koob and Volkow, 2010). Furthermore, the
dual process model on addiction proposes that an imbalance between a
hyper-sensitized impulsive system, which is responsible for cue-re-
activity, and a compromised reflective or control system (including
inhibition of impulses) are important in the development of addiction
(Bechara, 2005; Gladwin et al., 2011; Volkow et al., 2004, 2015).
Over the past two decades, multiple studies have focused on the
relationship between chronic substance use and response inhibition, but
findings have been equivocal. Inhibitory impairment has been asso-
ciated with chronic use of some substances (e.g., cocaine, ecstasy,
methamphetamine, tobacco, and alcohol) but not for others (e.g.,
opioids, cannabis, see for a meta-analysis, Smith et al., 2014). Results
also vary in studies of single substances. For instance, heavy drinkers
have been reported to make more commission errors than light drinkers
on the Go/No-Go task (GNG, Kreusch, Quertemont et al., 2014), while
alcohol-dependent and control participants did not differ significantly
on the same measure (Kamarajan et al., 2005). Two main issues might
explain these conflicting findings, namely the phenomenon of poly-
substance use and the use of extreme group designs (i.e., comparing
control participants and problematic or disordered substance users). In
addition, sample demographics and task characteristics are often not
taken into consideration. In order to address these issues in this mega-
analysis, we aimed to investigate the relationship between inhibition
and use of multiple substances by analyzing individual-level data, while
taking demographics and task characteristics into account. In doing so,
we did not exclusively focus on populations diagnosed with substance
use disorders (SUD, American Psychiatric Association, 2013).
1.1.2. Experimental paradigms: the Go/No-Go task and the Stop-signal task
Successful suppression of motor responses can involve distinct be-
havioral processes such as “action restraint” or “action cancellation”
(Schachar et al., 2007). Action restraint refers to stopping a prepared
but not yet initiated response, which is commonly measured using the
GNG and its variants, such as Conners’ continuous performance task
(Conners and Sitarenios, 2011; Donders, 1969). These tasks focus on the
ability to withhold responding if a no-go stimulus is presented. The
main variables of interest are the rate of commission errors (i.e., failures
to inhibit a response to no-go targets or false alarms), the rate of
omission errors (i.e. failures to respond to go targets, or misses), and the
response time (RT) to go stimuli. A relatively high rate of commission
errors and a short go RT reflects suboptimal inhibition (Smith et al.,
2014).
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By contrast, action cancellation refers to stopping a response that is
already underway. It is typically measured using the Stop-signal task
(SST, Logan, 1994). In this paradigm, each trial starts with the pre-
sentation of a go signal that requires an overt response such as a button
press. On a subset of trials (typically around 25%), the go signal is
followed by a stop signal after a certain interval (stop-signal delay,
SSD), upon which participants should inhibit their already initiated go
response. Usually, an adaptive tracking algorithm controls the SSD,
such that there is a 50% probability of inhibiting the response. A horse-
race model, assuming an independent race between the ‘go’ and ‘stop’
processes, affords the estimation of the stop-signal reaction time (SSRT,
Logan, 1994). Given that the response could not be withheld on n
percent of all stop trials (usually around at 50%), SSRT is calculated by
subtracting the mean SSD from the go RT that marks the nth percentile
in the go RT distribution (Band et al., 2003).
In contrast to the GNG, the latency of the go response and the la-
tency of the stop process are considered to be independent (Logan and
Cowan, 1984). Thus, a longer SSRT reflects an inhibitory deficit,
whereas a longer go RT is interpreted as a lack of attention among other
influencing factors (preparation, choice, and speed-accuracy trade-off,
Lijffijt et al., 2005).
In addition to the GNG and the SST, other experimental paradigms,
such as the Stroop (Stroop, 1992) and Eriksen Flanker tasks (Eriksen
and Eriksen, 1974) have been proposed to measure inhibitory capa-
cities. However, these paradigms measure distractor inhibition rather
than motor response inhibition (Nigg, 2000; Ridderinkhof et al., 2004).
To keep the present review focused and allow for straightforward
comparisons of results, we only included studies using the GNG and
SST.
1.2. Research gaps and research needs
1.2.1. Previous meta-analyses and reviews
To date, there are at least nine published meta-analyses or review
papers examining the relationship between inhibitory control and long-
term substance use or behavioral addiction. In terms of scope, these
studies can be classified into three categories. First, literature overviews
focusing on a single substance (e.g., alcohol: Aragues et al., 2011;
Stavro et al., 2013) or non-substance related disorder (e.g., gambling
disorder: Chowdhury et al., 2017; Moccia et al., 2017). These reviews
associated alcohol use with prolonged inhibition impairment, up to one
month after abstinence (Stavro et al., 2013) and detoxified alcohol-
dependent patients showed poor inhibition compared with healthy
controls (Aragues et al., 2011). Polysubstance use was not system-
atically described or controlled for in either of the review studies on
alcohol. Individuals with gambling disorder without comorbid SUD
were reported to show large inhibition deficits (Chowdhury et al.,
2017), which was attributed to impaired activity in prefrontal areas
(Moccia et al., 2017). Second, other reviews focused on drawing gen-
eral conclusions across multiple substances. For instance, Lipszyc and
colleagues found that substance users generally did not differ sig-
nificantly from controls in SST (Lipszyc and Schachar, 2010) and GNG
performance (Wright et al., 2014). However, such a review does not
provide a clear profile for the effects of these substances in isolation or
of specific interactions (i.e., greater than additive or compensation ef-
fects). A third category of literature reviews included multiple sub-
stances and the results were specified by the substance. Examples in-
clude a recent systematic review focused on neuroimaging findings
(Luijten et al., 2014) and a meta-analysis focused on behavior (Smith
et al., 2014). The latter meta-analysis indicated that inhibitory deficits
were apparent for heavy use/disorders related to cocaine, ecstasy,
methamphetamine, tobacco, alcohol, and gambling but not for opioids
or cannabis, without testing the interaction effect of using multiple
substances (Smith et al., 2014). In sum, the current findings and con-
clusions of reviews and meta-analyses are rather inconsistent. If a
conclusion can be drawn, it appears to be the counterintuitive
conclusion that reviews and meta-analyses that focused on a specific
addictive substance or behavior are more likely to report a significant
association with inhibitory control compared to those reporting on
multiple substance use. Importantly, none of these reports have con-
sidered several key variables that might bias the results, which will be
highlighted in the next section.
1.2.2. Important factors to consider
1.2.2.1. Polysubstance use. Polysubstance use broadly refers to the
consumption of more than one drug over a defined period, either
simultaneously or at different times (Connor et al., 2014; Subbaraman
and Kerr, 2015). This involves different sub-categories, namely using
different substances, the dependence of one substance and co-use of
other substances or dependence on multiple substances. For instance,
tobacco smoking is strongly associated with alcohol and marijuana use
(Connor et al., 2014), opioids and benzodiazepines are often prescribed
simultaneously (Jones et al., 2012), and stimulants users are more
likely to be heavy drinkers (McCabe et al., 2005). Note that there is
some evidence indicating that concurrent use of substances can lead to
additionally toxic effects because of a toxic metabolite, as was reported
for alcohol and cocaine (Pennings et al., 2002). It is also possible that
the use of one substance decreases the negative effect of another
substance, as found with alcohol and cannabis (Schweinsburg et al.,
2011). Hence, studying interactions between drugs on neurocognitive
functions is important, given the frequent occurrence and possible
interaction effects. However, studies comparing substance users versus
non-users or light users have typically focused on the primary substance
of concern, while ignoring secondary substances. Up to now, only a few
studies have investigated the relationship between polysubstance use
and inhibition (Gamma et al., 2005; Moallem and Ray, 2012; Verdejo-
García et al., 2007). Heavy drinking smokers did not show poorer SST
response inhibition than smokers only and heavy drinkers only
(Moallem and Ray, 2012). Similarly, ecstasy polysubstance users did
not show more strongly disturbed inhibitory brain mechanisms
compared with controls (Gamma et al., 2005), and cocaine and
heroin polysubstance users showed similar commission error rates as
controls in the GNG (Verdejo-García et al., 2007). A limitation of the
latter two studies is that the greater-than-additive effect could not be
examined without a group of single substance users. The lack of studies
calls for a synthesis of research that does take polysubstance use into
account.
1.2.2.2. Substance use as a continuous variable. All the above-mentioned
reviews and meta-analyses included comparisons between a control or
light user group and a heavy or problematic user group. Scores retained
as a result of such extreme group designs are often coded and analyzed
in terms of low versus high, reducing individual differences into a
binary code. This practice involves ignoring individual-differences of
substance use in favor of creating quasi-arbitrary groups assumed to be
homogeneous on the variable of interest (MacCallum et al., 2002;
Royston et al., 2006; Preacher et al., 2005). In the current study, we
aimed to quantify substance use as a continuous variable.
1.2.2.3. Abstinence. Studies on long-lasting effects of substance use
have generally been conducted by testing recently abstinent users. With
respect to response inhibition, some studies have found that abstinence
from cocaine, methamphetamine and heroin normalized inhibitory
function (Morie et al., 2014; Schulte et al., 2014), however, one study
found sustained suboptimal performance after heroin abstinence (e.g.,
Fu et al., 2008). In addition, the duration of abstinence appears to
moderate the return to normal functioning, which may explain these
conflicting findings (Schulte et al., 2014). In order to preclude this as a
confounder, we did not include studies on abstinence in (formerly)
dependent users. All participants indicated substance use in everyday
life, but were requested to refrain from using all substances (in most
cases excluding tobacco) 24 h to one week before testing.
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1.2.2.4. Individual-level and task-level variables. Some individual-level
and task-level factors are known to affect inhibitory control and are
therefore included in this mega-analysis, including the demographic
variables age, sex, and education years. For GNG, six task parameters
were controlled for: no-go percentage, number of experimental trials,
working memory load (taxed or not), substance-related stimuli (used or
not), cued GNG or not, and task complexity. For the SST, five task
parameters were controlled for: number of experimental trials, stop-
trial percentage, SSD settings, stop-signal modality, and SSRT
calculation method. Reasons for controlling these confounders are
based on a large primary literature on these tasks and are
summarized in Supplementary Materials S1. Except for sex, for which
the interaction with substance use was considered, all other factors
were only controlled for regarding their main effect.
1.3. Why a mega-analysis rather than a meta-analysis?
A meta-analysis combines the summary statistics (i.e., effect sizes of
included studies), while a mega-analysis combines the raw individual
data from different studies. The latter method allows studying the
combined effect of individual characteristics (cf. Price et al., 2016) and
examining the interaction effect of multiple substances used with en-
hanced statistical power (Riley et al., 2010). Therefore, we im-
plemented a mega-analysis with individual-level data.
1.4. The goal of the current study
Our primary goal was to examine the main and interaction effects of
various kinds of long-term substance use on response inhibition. As the
interaction effects of substance use on inhibition are rarely investigated
and reported, we explore these interactions in the current study. We do
so while controlling for demographics (e.g., age, sex, education years)
and task-related factors (e.g., no-go percentage, number of trials,
whether stimuli are substance-related) that likely explain performance
variance between studies and individuals. Interactions between sub-
stance use and sex were also included. Based on the literature reviewed
above, we tested the following hypotheses: 1) According to Smith et al
(2014) and other findings (Colzato et al., 2007; Fillmore and Rush,
2002; Quednow et al., 2007), we assumed that the inhibitory deficit
would be more pronounced in users of psychostimulants (e.g., cocaine,
ecstasy, methamphetamine, tobacco, and alcohol), especially for co-
caine and amphetamines, given the known neuropsychopharmacology
of the cortical and subcortical networks underlying impulse control
(i.e., the right dorsolateral and inferior frontal cortices, Koob and
Volkow, 2010; Smith et al., 2014); 2) Given the literature, and as a
validation of our individual-level mega-analysis, we expect some de-
mographics (e.g., age and sex) and task characteristics (e.g., no-go
percentage, whether stimuli are substance-related) to be associated
with inhibition performance (see for expected directions of effects,
Supplementary Materials S1).
2. Method
2.1. Study identification and selection
PsycINFO, Medline, EMBASE, Web of Science, CINAHL, and
Cochrane Library were searched until 01/03/2016. Search terms and
synonyms indicating substance use (alcohol, amphetamine, cocaine,
cannabis, heroin, ketamine, methamphetamine, benzodiazepines,
gambling, gamer, and internet addiction) were combined with terms
indicative of inhibition (go/no-go, inhibitory control, inhibitory pro-
cess, response inhibition, stop task, etc.). Published meta-analyses and
reviews were also checked for additional studies (Horsley et al., 2011).
Although behavioral addictions (e.g., gambling, internet addiction)
were initially included, there were too few relevant studies to allow
further analyses.
2.1.1. Eligibility criteria
The first author (YL) assessed the eligibility of all records using the
following initial inclusion criteria: (a) presented in English; (b) con-
ducted on human participants; (c) reported at least one measure from
the following: no-go commission errors or go RT in the GNG; SSRT or go
RT in the SST; (d) reported use of at least one kind of substance (e.g.,
alcohol, tobacco, cannabis, amphetamine, cocaine, ecstasy). Note that
we included behavioral data from fMRI/EEG studies if available. In
addition, we ran supplementary analyses to investigate whether in-
hibition performance varied with study type (behavioral/EEG/fMRI). It
turned out that study type did not systematically influence behavioral
performance (see Supplementary Materials S2). We excluded studies (a)
that presented stop signals using a single SSD, as this is known to induce
a performance strategy of delayed responding (Logan, 1994); (b) in
which the percentage of no-go or stop trials was higher than 50%, as
this is known to invalidate the task (Nieuwenhuis et al., 2004; Randall
and Smith, 2011); (c) that focused on the acute effects of substances on
inhibition; (d) that recruited participants with a family history of sub-
stance dependence; (e) that excluded polysubstance users; (f) with
participants that already received treatment for SUD or abstained from
substance use; (g) with participants younger than 18. The exclusion of
both intoxicated and abstinent consumers may have kept heavily af-
fected/addicted participants from being included in the sample.
After applying the inclusion and exclusion criteria by YL, a second
rater (author YG) assessed the eligibility of a random subset (20%) of
the records and obtained 100% agreement. Authors of eligible studies
were invited via email to contribute raw data. Repeated attempts were
made (i.e., four reminders were sent) if no response was received.
Corresponding authors of the identified studies were asked to share
their raw individual data, following our instructions on data require-
ments. The ‘essential variables’ included a set of pre-identified vari-
ables, including sociodemographic characteristics (e.g., age, sex, and
education), typical alcohol and tobacco use (as alcohol and tobacco are
two most commonly used substances), and task performance (Table
S1a, S1b). ‘Optional variables’ (Supplementary Materials S3) included
other demographic information recorded (e.g., race), other substance
use (e.g., cocaine, cannabis) and questionnaires administered (e.g.,
Alcohol Use Disorder Identification Test (AUDIT), Saunders et al.,
1993). The ‘optional variables’ were defined in a more flexible format
with open questions. A study was included in our mega-analysis only if
information about all ‘essential variables’ could be provided.
2.1.2. Quality assessment and data extraction
As the quality of included studies can influence mega-analysis in
unpredictable ways (i.e., shortcomings in original studies will be car-
ried over to the mega-analysis and thus weaken its conclusions, Müller
et al., 2019), a quality assessment of original studies was conducted.
The methodological quality of studies was assessed by two authors (YL
and YG) separately. We used the National Heart, Lung, and Blood In-
stitute (NHLBI) Quality Assessment Tool for Observational Cohort and
Cross-Sectional Studies, which is widely used and recommended by
Cochrane for quality assessment of observational and cross-sectional
studies (Table S2, National Heart, Lung and Blood Institute, 2014). The
total agreement (Good/Fair/Suboptimal) between assessors was high
(GNG: 20/24= 83%, SST: 16/20=80%). Inter-rater reliability, mea-
sured using Spearman's rank correlation coefficient was high for GNG
(r=0.84, p < 0.001) and moderate for SST (r=0.56, p= 0.01,
Kendall, 1938).
All provided data, including predictors (i.e., substance use, demo-
graphics, task characteristics) and dependent variables were merged
into four datasets separated based on the four dependent variables (i.e.,
the commission error rate in GNG, go RT in GNG, SSRT in SST, and go
RT in SST. As speed-accuracy trade-off is a potential issue in GNG (Zhao
et al., 2017), a balanced integration score was calculated (Liesefeld and
Janczyk, 2019). Main results applying this score as the outcome are
presented in Supplementary Materials S4. The first author (YL)
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Table 1
Description of included GNG studies (dependent variable is commission error rate).
(continued on next page)
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performed the data merging, which was verified by two authors (RW
and WW).
2.1.3. Publication bias check
To examine whether significant findings in the original papers are
indicative of evidential value, a p-curve was calculated and plotted
(Simonsohn et al., 2015). In a p-curve, the x-axis represents p-values
below 0.05, and the y-axis represents the percentage of studies yielding
such a p-value. A right-skewed p-curve indicates evidential value,
whereas a left-skewed p-curve, many p-values just below 0.05, may be
indicative of flexibility in data analysis (Simonsohn et al., 2015). If the
data did not indicate evidential value, a 33% power test is performed to
examine whether the absence of evidential value is due to insufficient
power. A p-curve disclosure table was added in Supplementary Mate-
rials (Table S3) according to Simonsohn et al. (2015). P-curves and
corresponding analyses were conducted using the p-curve app 4.06
(http://www.p-curve.com/app4, 2018).
2.2. Individual participant data meta-analysis
The analysis was conducted in the following steps: 1) apply addi-
tional exclusion criteria to the merged datasets; 2) standardize all
continuous independent variables; 3) determine substance-related one-
way variables; 4) dummy code all discrete variables; 5) determine and
generate substance-related interaction variables; 6) multiple imputa-
tions of the missing values using all main and interaction variables; 7)
build the linear mixed regression model with fixed effects of all pre-
dictors and a random intercept; 8) variable selection by stepwise
backward elimination. These eight steps are outlined in more detail
below.
2.2.1. Construction of the database
2.2.1.1. Individual and group exclusion criteria. The data from the
included studies were stacked into a single data file for each
dependent variable, with unique identifiers for each study and for
each participant. We further applied some minimal exclusion criteria to
the individuals. That is, we excluded a participant if (1) he/she was
younger than 18 years old; (2) he/she had missing data on all indices of
substance use; (3) the dependent variable of current analysis (e.g.,
commission error rate) was missing; (4) SSRT was negative.
A group of substance users from a certain study was excluded if the
substance was not included as a predictor in the model. This happened
when there was limited data provided for that substance (see criteria in
2.2.1.3.1). For example, if it was concluded that opiate use was assessed
insufficiently across all studies, we did not add opiate as a predictor.
Consequently, opiate users were excluded from the analysis. The ex-
cluded cases and groups from each study are listed in Tables 1 and 2.
2.2.1.2. Standardization of independent variables
2.2.1.2.1. Continuous variables. Demographics like age and
education level were transformed respectively into continuous
variables years and years of education according to the education
system in the country where the study was conducted. Task
characteristics such as no-go percentage and number of trials in both
tasks were also treated as continuous variables.
Alcohol consumption was converted into the continuous variable
grams of ethanol per month. Data on alcohol consumption were pro-
vided in two different ways. Most researchers provided data based on
timeline follow-back (TLFB). These data were either already in grams
per month or could be transformed by making use of standard drinks
adjusted for country (Cooper, 1999). Some studies only had data from
more general questionnaires. For instance, three studies (de Ruiter
et al., 2012; Luijten et al., 2013a; Rossiter et al., 2012) provided the raw
data of the AUDIT (Saunders et al., 1993). In that case, we multiplied
midpoints of item 1 (frequency), midpoints of item 2 (drinking days per
month) and standard drinks in the country where the study took place.
Similarly, four studies (Littel et al., 2012; Luijten et al., 2011; Luijten,
Meerkerk et al., 2015; Luijten et al., 2013b) provided Quantity
Table 1 (continued)
Note: go-RT: reaction time for correct go trials; M: Mean; SD: Standard Deviation; NA: Not Available; AUDIT: Alcohol Use Disorder Identification Test; VAT:
Videogame Addiction Test; AUQ: Alcohol Use Questionnaire; FTND: Fagerström Test for Nicotine Dependence; SDS: Severity of Dependence Scale.
*Unpublished dataset at time of searching literature.
Why comparisons between substance users and controls could not be obtained from the original paper
ainterested in the difference between the increasing and decreasing limb of BAC but we only used baseline data when participants were sober.
bthe correlation between commission error rate and binge score was not reported.
cfocused on the experimental effect (different kinds of cued GNG) instead of the individual difference.
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Table 2
Description of included SST studies (dependent variable is SSRT).
-
(continued on next page)
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Frequency Variability (QFV) score (Lemmens et al., 1992). Again, items
of quantity, frequency, and standard drinks were multiplied together.
Smoking was coded as cigarettes per day. Two studies (Moallem and
Ray, 2012; Rossiter et al., 2012) only had data from the Fagerström Test
for Nicotine Dependence (FTND, Heatherton et al., 1991). In these
cases, the midpoint of the answer to item “How many cigarettes a day
do you smoke” was used for daily cigarette use. One study used a self-
developed 7-point Likert scale for the past 6 months tobacco con-
sumption, for which we estimated daily cigarette use with the midpoint
scores (Ames et al., 2014). Alcohol and tobacco use were standardized
across the full dataset. All the other substance use variables had to be
treated as dichotomous variables, as insufficient information was pro-
vided for treating it as a continuous variable in the model (see details
below).
2.2.1.2.2. Dichotomous variables. For interpretability, dichotomous
variables were effect-coded with value +1 or -1. Except for alcohol and
tobacco use, other substances were coded as ‘lifetime use (yes= 1/no
= -1)’.
Four dummy task-characteristics were defined to classify the GNG
studies: ‘working memory load (low/high)’, ‘substance-related (yes/
no)’ ‘cued GNG (yes/no)’, and ‘task complexity (low/high)’. High
working memory load, substance-related, cued GNG versions and
complicated tasks were assigned the value of 1 (otherwise -1). Tasks
with high working memory load were also assigned a value of 1 for task
complexity as the association between stimuli and response was more
complicated in these tasks.
Similarly, for the SST, three dummy task characteristics were ex-
tracted, including ‘stop-signal modality (visual/auditory)’, ‘SSD (fixed/
staircase-tracking)’ and ‘SSRT calculation (integration/others)’. These
variables were assigned a value of 1 if auditory stop signals were used;
staircase-tracking procedure for SSD; and integration method for SSRT
calculation (otherwise -1).
2.2.1.3. Identification and generation of substance-related
variables. Except for alcohol use and tobacco use, other kinds of
substances had missing data as not all studies provided information.
Data provided varied in the level of detail, the way questions were
asked, and the substances of main interest. For instance, depending on
Table 2 (continued)
Note: SSD: Stop-Signal Delay; SSRT: Stop-Signal Reaction Time; go-RT: reaction time for correct go trials; M: Mean; SD: Standard Deviation; NA: Not Available; AUQ:
Alcohol Use Questionnaire; DAST: Drug and Abuse Screening Test; AUDIT: Alcohol Use Disorder Identification Test; SOGS: South Oaks Gambling Screen; BIS-11:
Barratt Impulsiveness Scale.
*unpublished dataset at the time of literature search.
Why comparisons between substance users and controls could not be obtained from the original paper.
afocused on how genes moderated impulsivity.
bonly reported MRI results.
cfocused on experimental effect rather than individual difference with a within-subject design.
dthe correlation between SSRT and binge score was not reported.
elongitudinal study, only baseline data was used.
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the primary substance of interest, some studies provided detailed
information for cannabis use but no information on cocaine use
(Bidwell et al., 2013), with an opposite pattern for others (Colzato
et al., 2007). In the following section, we explain the criteria for
including substance-related variables in the model.
2.2.1.3.1. One-way variables. Due to missing data, a criterion was
needed to include a variable in the model. We decided on a minimum of
100 participants per cell for a substance (which comes down to a power
of 0.94 for the effect size of 0.5). As a result, final models for the GNG
(both commission error rate and go RT) included cannabis, cocaine,
amphetamine, ecstasy, and hallucinogens, in addition to alcohol and
tobacco. For the SST (both SSRT and go RT), the final models included
cannabis, cocaine, and ecstasy in addition to alcohol and tobacco.
2.2.1.3.2. Two-way variables. There were two types of two-way
variables; the interaction of ×sex substance and×substance1 substance2. Variables of ×sex substance were created by
multiplying sex with substance directly. For the second type, in order to
evaluate whether there was sufficient data to assess these interactions,
we again applied a criterion for inclusion. For example, dummy coding
cannabis and cocaine use yielded a two by two table×cannabis (yes/no) cocaine (yes/no). The corresponding interaction was
only entered into the model if all four cells had more than 20 entries.
For alcohol and tobacco use, we dichotomized the data by a median
split for table construction only. We performed an additional analysis to
test whether the number of substances used was a predictor of
inhibition performance, and this was not the case (see Supplementary
Materials S5). The list of included two-way variables can also be found
in Supplementary Materials (Table S4a-S4d). Demographics (in
addition to sex) and task parameters could further moderate the
relationship between substance use and inhibition. This, however,
was not the focus of the current paper. In order to explore this
potential issue, we analyzed interactions between alcohol on the one
hand and demographics and task parameters on the other (see
Supplementary Materials S6).
2.2.1.3.3. Three-way variables. Three-way variables were generated
based on the ×substance1 substance2 variables combined with sex. The
corresponding variables were entered into the model only when all the
eight cells in the three-way table ×sex (male/female)×substance1 (yes/no) substance2 (yes/no) consisted of at least 10
entries. The list of three-way variables can be found in
Supplementary Materials (Table S4a-4d).
2.2.2. Missing data for independent variables and their interactions
In the analysis of GNG commission error rate, the percentage of
missing values ranged from 0 to 68.2% (highest:× ×alcohol hallucinogens sex) and in the GNG go RT analysis, it ranged
from 0 to 69.6% (highest: × ×alcohol hallucinogens sex). For the SST,
the percentage of missing values ranged from 0 to 84% for the SSRT
(highest: × ×tobacco ecstasy sex) and from 0 to 83.2% for the go RT
(highest: × ×tobacco ecstasy sex, a full list of missing data per variable
can be found in Table S4a-s4d).
In order to deal with these missing data, we used multiple im-
putations (Rubin, 2004). The default imputation option in SPSS was
chosen. It first scans the data and determines the suitable method for
imputation (Monotone or Fully Conditional Specification, FCS; Dong
and Peng, 2013). All variables in the mixed regression model, including
the main and interactive predictors and the dependent variable, were
used for imputation. Apart from that, the discrete variable of ‘tobacco
lifetime use’ was also used, as some studies assessed tobacco use di-
chotomously (smokers/non-smokers). It has been suggested that the
number of imputations should be similar to the percentage of cases that
are incomplete (White et al., 2011) and the precision improves by in-
creasing the number of imputations (Bodner, 2008). Therefore, 100
complete data sets were generated, which were combined into a pooled
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Fig. 1. PRISMA for the mega-analysis detailing our search and selection decisions.
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result using the method proposed by Rubin (Rubin, 2004) and Schafer
(Schafer, 1997).
2.3. Statistical analysis
Backward elimination was used for variable selection. Initially, each
imputed dataset was analyzed with a linear mixed model including all
the above-mentioned main, second order, and third order effects as
fixed effects and a random intercept (for which a model summary can
be found in Tables S4a-S4d). We did not include random slopes and
thus assumed that predictors had similar effects in each study. The fixed
effects that were least significant (i.e., the one with the largest p-value)
were removed and the model was refitted. Each subsequent step re-
moved the least significant variable in the model until all remaining
variables or its higher order variables had p-values smaller than 0.05
(Draper and Smith, 2014). For instance, if the variable ×alcohol tobacco
was significant, then variables of alcohol and tobacco would also be
included in the model, irrespective of their independent significance.
3. Results
3.1. Study selection
3.1.1. Summary of authors’ responsiveness
Applying the inclusion and exclusion criteria resulted in a sample of
153 potentially eligible studies (Fig. 1). Out of these targeted papers, 4
researchers responded that they no longer had access to the datasets, 21
declined to participate, 52 did not respond to our invitation and 11 did
not have all the basic information we asked for. In total, we obtained
raw data from 65 studies. Out of these, 22 had to be excluded because
the authors could not provide all the ‘essential variables’, such as data
on monthly alcohol use in grams was unavailable (9 studies), missing
data of tobacco use (5 studies), participants were abstaining from
substance use (3 studies), participants were younger than 18 years old
(2 studies), uncommon tasks were used (2 studies) and unsuitable
outcome measures (1 study, provided stop latency instead of SSRT). The
full list can be found in Supplementary Materials S7. The final dataset
for the GNG comprised of 23 independent datasets from 24 papers (in
some cases, more than one paper was published with the same dataset).
For the SST, 19 datasets from 20 papers were included. In addition, one
study administered both GNG and SST; therefore 43 unique studies
were included in total.
The final list of eligible studies was slightly different from the list of
studies included in Smith and colleagues meta-analysis on summary
statistics (Smith et al., 2014). For the GNG, there were 11 studies in
common. For the SST, there were 6 studies in common. These dis-
crepancies were related to different research questions. Since we aimed
to assess the unique and combined effects of different substances, while
Smith and colleagues focused on the unique effect of a single substance,
some studies that were excluded by Smith and colleagues were included
here and vice versa. In addition, individual data mega-analysis typically
has a lower response rate compared to traditional meta-analysis, as it
requires more work from the researchers (Riley et al., 2010, 2007).
3.1.2. Study description
Tables 1 and 2 present descriptive characteristics of the included
GNG and SST studies before imputation, respectively.
3.1.3. Findings in original studies
For GNG, out of the 24 studies included, 9 (37.5%) reported that
(heavy/problematic) substance users/excessive gamers made more
commission errors than controls/light users (3 for alcohol, 2 for to-
bacco, 1 for ecstasy, 1 for inhalant and 2 for excessive gamers), 1
(4.2%) reported opposite findings (i.e., opiate users made fewer com-
mission errors compared to controls), 11 (45.8%) reported no sig-
nificant differences (5 for alcohol, 2 for tobacco, 1 for ecstasy, 1 for
inhalant and 2 for polysubstance use), and 3 (12.5%) didn’t have such
an analysis (See Tab
footnote). For the SST, out of the 20 studies, 5 (25%) reported
substance users/gamblers had longer SSRT than controls (2 alcohol, 2
cocaine and 1 pathological gambling), 1 (5%) reported the opposite
direction (alcohol), 8 (40%) reported no difference (3 alcohol, 2 to-
bacco, 1 cannabis, 1 cocaine, and 1 pathological gambling) and 6 (30%)
did not provide such an analysis (see Table 2 footnote).
3.2. Quality assessment
We rated the methodological quality of the studies according to the
Table 3a
Quality assessment scores of included GNG studies according to the NHLBI Quality Assessment Tool.
Study Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Q14 Quality Rating
Ames et al. (2014) yes yes NR yes no no no yes yes no yes NR NA yes fair
Claus et al. (2013) yes yes NR yes no no no yes yes no yes NR NA yes good
Hendershot et al. (2015) yes yes NR yes no yes yes yes yes yes yes NR NA yes fair
Kamarajan et al. (2005) yes yes NR no no no no no yes no yes NR NA yes fair
Kreusch et al. (2014) yes yes NR yes yes no no yes yes no yes NR NA yes good
Littel et al. (2012) yes yes NR yes no no no yes yes no yes NR NA yes fair
López-Caneda et al. (2014) yes yes NR yes no yes yes yes yes yes yes NR NA yes good
Luijten et al. (2011) yes yes NR yes no no no no yes no yes NR NA yes fair
Luijten et al. (2013a) yes no NR CD yes no no no yes no yes NR NA yes fair
Luijten et al. (2013b) yes yes NR CD no no no no yes no yes NR NA yes fair
Luijten et al. (2015) yes yes NR yes no no no yes yes no yes NR NA yes fair
Mahmood et al. (2013) yes yes NR yes no yes yes yes yes yes yes NR NA yes good
Petit et al. (2014) yes yes NR yes yes no no yes yes no yes NR NA yes good
Paz et al. (2018) yes yes NR yes no yes yes yes yes yes yes NR NA no fair
Pike et al. (2015) yes yes NR yes yes no no no yes no yes NR NA yes fair
Quednow et al. (2007) yes yes NR yes no no no yes yes no yes NR NA yes fair
Rass et al. (2014) yes yes NR yes yes no no yes yes no yes NR NA yes good
Roberts and Garavan (2010) yes no NR yes no no no no yes no yes NR NA yes fair
Roberts et al. (2013) yes no NR yes no no no no yes no yes NR NA yes suboptimal
Rossiter et al. (2012) yes yes NR yes no no no yes yes no yes NR NA yes good
Takagi et al. (2011) yes yes NR yes yes no no yes yes no yes NR NA yes fair
Takagi et al. (2014) yes yes NR yes yes no no yes yes no yes NR NA no fair
Verdejo-García et al. (2012) yes yes NR yes yes yes yes yes yes no yes NR NA yes good
Wetherill et al, (2013) yes yes NR yes no yes yes no yes no yes NR yes yes good
Note: CD: cannot determine; NA: not applicable; NR: not reported; Meanings of criteria Q1-Q14 can be found in Table S2.
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NHLBI assessment tool (see Tables 3a and 3b). For the GNG, most
(58.3%) of the studies were of intermediate quality, 37.5% of high
quality and 4.2% of suboptimal quality. For the SST, 40% of studies
were of high quality and another 60% of intermediate quality. The main
limitations were small sample size, especially for the studies focused on
neuroimaging findings, and insufficient control of confounders such as
the history of other kinds of drug use. For a few studies, the population
was not fully described, lacking information of where and when the
participants were recruited. To explore whether different study types
differ in methodological quality, we did a chi-square test based on
Tables 3a and 3b. The results indicate that the percentages of studies of
good, fair and suboptimal quality did not differ between behavioral (10/
23, 13/23, 0/23), EEG (4/8, 3/8, 1/8) and fMRI (3/12, 9/12, 0/12)
studies (χ2 (4, N=44)=6.51, p= 0.15).
3.3. Publication bias check
To examine evidential value in the original studies, a p-curve was
created (Supplementary Materials Fig. S1). Out of the 31 effect sizes
(unavailable for some studies), 11 were statistically significant (p <
0.05), with 8 p < 0.025. The p-curve analysis on the association be-
tween substance use and response inhibition indicated no evidential
value (full p-curve z = −0.98, p= 0.16; half p-curve z=0.58, p=
0.72). However, this was likely due to a lack of power (33% power test,
full p-curve z = −0.95, p= 0.17).
3.4. Main outcomes
3.4.1. GNG: no-go commission errors
None of the substance-related variables or their interactions had a
significant effect on the commission error rate. Among all other vari-
ables, two demographic variables and three task characteristics sig-
nificantly predicted commission error rates. Age significantly predicted
commission error rate (β = −0.01, p<0.01, 95% CI [−0.02, 0.00]),
indicating that older participants showed decreased commission error
rates. Education years also significantly predicted commission error
rate (β = −0.01, p = 0.03, 95% CI [−0.02, 0.00]), indicating the
higher the educational level, the lower the commission error rates. The
nominal variable working memory load had a significant effect on
commission error rate (β = 0.10, p<0.01, 95% CI [0.07, 0.14]), in-
dicating that when working memory load was high, participants made
more commission errors. The no-go percentage had a significant effect
on commission error rate (β = −0.04, p<0.01, 95% CI [−0.07,
−0.02]), such that the higher the no-go percentage, the lower the rate
of commission errors. The number of trials also had a significant effect
on commission error rate (β = 0.04, p<0.01, 95% CI [0.02, 0.07]),
indicating higher commission error rates when there were more trials.
3.4.2. SST: SSRT
Lifetime cannabis use significantly predicted SSRT, with users
showing longer SSRT than non-users (β = 5.59, p = 0.03, 95% CI
[0.41, 10.77]). Tobacco use was positively, although not significantly,
associated with SSRT (β = 3.21, p = 0.06, 95% CI [−0.13, 6.55]),
indicating that the more tobacco was consumed, the longer SSRT. The×tobacco cannabis interaction also had a significant effect on SSRT (β
=−4.19, p= 0.03, 95% CI [−8.03, −0.37], Fig. 2). Post-hoc analyses
were performed by splitting the imputed data sets and fitting the same
restricted model without the interaction term. These analyses revealed
that for the cannabis non-users, higher tobacco use was associated with
longer SSRT (β = 6.44, t=2.70, p < 0.01). For cannabis users, no
effect of tobacco use on SSRT was observed (β = −0.15, t = −0.05,
p= 0.96). When split based on cigarette smoking (median-split of z-
score), the following effects were obtained: for low tobacco users,
cannabis lifetime users did not differ significantly from cannabis non-
users in SSRT (β=7.62, t=1.90, p= 0.06). A similar finding was
observed among high tobacco users (β=4.80, t=1.74, p= 0.08).
Education years also significantly predicted SSRT (β = −9.33,
p<0.01, 95% CI [−12.88, −5.80]), indicating that the higher the
education level, the shorter the SSRT. Age significantly predicted SSRT
(β = 13.46, p<0.01, 95% CI [9.29, 17.63]), with an increase in SSRT
along with an increase in age. The number of trials also significantly
predicted SSRT (β = −17.44, p<0.01, 95% CI [−30.60, −4.28]),
indicating a decrease in SSRT when there were more trials. In addition,
stop-signal modality had an effect on SSRT (β = −28.58, p = 0.01,
95% CI [−50.61, −6.56]), indicating that auditory stop signals in-
duced shorter SSRT compared to visual stop signals. SSD also had a
significant effect on SSRT (β = −33.29, p = 0.04, 95% CI [−64.61,
−1.96]), indicating that the staircase-tracking procedure resulted in
shorter SSRT compared to the fixed SSD procedure.
For both SSRT and commission error rate, models including the
interaction between alcohol use on the one hand and demographics and
task parameters on the other resulted in largely comparable findings as
Table 3b
Quality assessment scores of included SST studies according to the NHLBI Quality Assessment Tool.
Study Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Q14 Quality Rating
Bidwell et al. (2013) yes yes NR yes yes no no yes yes no yes NR NA yes good
Bø et al. (2016) yes yes NR yes yes no no yes yes no yes NR NA yes good
Bø et al. (2016) yes yes NR yes no no no yes yes no yes NR NA yes fair
Colzato et al. (2007) yes yes NR yes no no no no yes no yes NR NA yes fair
Courtney et al. (2012) yes yes NR yes yes no no yes yes no yes NR NA yes good
Courtney et al. (2013) yes yes NR yes yes no no yes yes no yes NR NA yes good
de Ruiter et al. (2012) yes yes NR no no no no yes yes no yes NR NA yes fair
Filbey and Yezhuvath (2013) yes yes NR yes no no no yes yes no yes NR NA yes fair
Fillmore and Rush (2002) yes yes NR yes no no no no yes no yes yes NA yes fair
Galván et al. (2011) yes yes NR yes no no no no yes no yes NR NA yes fair
Glass et al. (2009) yes no NR no no yes yes yes yes no yes yes NA yes good
Karoly et al. (2014) yes yes NR yes no no no yes yes no yes NR NA no fair
Kräplin et al. (2015) yes yes NR yes yes no no yes yes no yes NR NA yes good
Moallem and Ray (2012) yes yes NR yes yes no no yes yes no yes NR NA yes good
Papachristou et al. (2012a) yes yes NR yes no no no yes yes no yes NR NA yes fair
Papachristou et al. (2012b) yes yes NR yes no no no yes yes no yes NR NA yes fair
Paz et al (2018) yes yes NR yes no yes yes yes yes yes yes NR NA no fair
Tsaur et al. (2015) yes yes NR yes yes no CD yes yes no yes NR yes yes fair
Vonmoos et al. (2013) yes yes NR yes yes yes CD yes yes no yes NR NA yes good
Zack et al. (2015) yes yes NR yes yes no no no yes no yes NR NA yes fair
Note: CD: cannot determine; NA: not applicable; NR: not reported; Meanings of criteria Q1-Q14 can be found in Table S2.
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presented here2 . Only in the GNG, an interaction between alcohol use
and age appeared (β=0.01, p= 0.02, 95% CI [0.001, 0.02]). For light
drinkers, older people made less commission errors (β = -0.02, t =
−2.56, p= 0.01), which was in line with the main effect of age.
Whereas for heavy drinkers, this relationship was absent (β =−0.01, t
=−1.50, p= 0.14). All other interactions with alcohol were found to
be non-significant (Supplementary Materials S6).
Outcomes for go RT in GNG and SST can be found in Supplementary
Materials S8. Briefly, older people had longer go RT in both GNG and
SST. Higher educated people had shorter go RT in SST. Although the
interaction between cocaine and tobacco had an effect on go RT in SST,
post-hoc analysis revealed no significant simple effect.
4. Discussion
Previous individual studies, reviews, and meta-analyses in-
vestigating inhibitory control deficits in relation to long-term substance
use and SUD have provided mixed results (Luijten et al., 2014; Smith
et al., 2014; Wright et al., 2014). These inconsistent findings might at
least partly be due to insufficient control of frequently occurring
polysubstance use. In addition, studies differed in sample demographics
and task-related variables and used extreme group designs. The current
mega-analysis aggregated data of 3610 individuals, from 43 studies, in
which polysubstance use, demographics, and task parameters were in-
cluded in the prediction of inhibition performance by means of an
imputed multilevel analysis. Most of the included studies were of
medium to high quality, which validates the overall conclusions drawn.
Surprisingly, our overall pattern of results indicated that most types of
substance use did not show an association with response inhibition.
While for most substances no effects were found, lifetime cannabis use
was found to be associated with impaired inhibition, as indexed by an
increased SSRT in the SST. Tobacco use was also associated with im-
paired inhibition as indexed by the same variable. In addition, an in-
teraction between lifetime cannabis and tobacco use was found on
SSRT, which indicated a strong positive relationship between daily
tobacco use and SSRT in participants who did not use cannabis (in-
dicating poorer inhibition), and the absences of such a relationship in
users smoking cannabis. In addition, demographic factors such as age
and years of education and task characteristics such as no-go percen-
tage, affected inhibition performance in the expected direction,
strengthening the credibility of the other results.
4.1. Response inhibition and substance use
The main significant finding of our mega-analysis was that lifetime
cannabis use was associated with prolonged response inhibition in the
SST. One possible explanation is that this could (partly) involve sub-
acute effects of cannabis use (i.e., lasting 7 h to 4 weeks after last
cannabis use, Gruber and Yurgelun-Todd, 2005; Pope and Yurgelun-
Todd, 1996; Schulte et al., 2014). Acute cannabis use (i.e., 0–6 hours
after last cannabis use) has been consistently reported to impair re-
sponse inhibition in the SST (Metrik et al., 2012; Ramaekers et al.,
2006). In contrast, findings of its long-term effect (i.e., 3 weeks or
longer after last cannabis use) were mixed (Crean et al., 2011), with
some confirming an impairing effect (Moreno et al., 2012), while others
did not (Tapert et al., 2007). To have a closer look at the effect of
cannabis, we compared cannabis daily users with less frequent users. A
linear mixed regression model was built with the fixed effect of ‘can-
nabis daily users (yes/no)’ and a random intercept. It indicated that
cannabis daily users did not differ from less frequent users on their
stopping latency (i.e., SSRT., β =−6.42, p= 0.90, 95% CI [−114.27,
127.10]), which does not support the hypothesis of subacute cannabis
effects. Despite conflicting behavioral findings of the relationship be-
tween cannabis use and response inhibition, abnormalities in neural
activation have often and more consistently been reported in relation to
acute as well as chronic cannabis use compared with non-users (sys-
tematic review: Wrege et al., 2014). Age of onset may have a moder-
ating effect on the neural effects of cannabis (Hester et al., 2009), but
we did not have sufficient data to test this hypothesis.
In line with previous findings, tobacco use tended to impair in-
hibition. Participants with a higher level of tobacco dependence de-
monstrated a lower level of response inhibition capacities (Billieux
et al., 2010), and smokers performed worse than non-smokers in a
smoking-related GNG (Luijten et al., 2011). However, it should be
noted that the main effect of tobacco use was qualified by a significant
interaction with cannabis use, indicating a negative effect of tobacco
use only in non-cannabis users. Another study reported that co-ad-
ministration of cannabis and tobacco attenuated the impairment in
delayed recall memory caused by cannabis alone (Hindocha et al.,
2017), and other reports have indicated weaker impairment on some
measures after polysubstance use (e.g., alcohol and cannabis,
Schweinsburg et al., 2011). One possible interpretation of these find-
ings is that cannabis has a protective effect when used together with
other substances such as alcohol and tobacco (cf., Viveros et al., 2006).
Due to the high co-occurrence of cannabis and tobacco use (Badiani
et al., 2015; Leatherdale et al., 2006), and the fact that concurrent to-
bacco use contributes to cannabis dependence symptoms (Ream et al.,
2008), further studies of the combined and single effects on response
inhibition are warranted to elucidate these findings.
What could explain the low evidence for a relationship between
(most) long-term substance use and inhibition? On closer inspection,
only 30% of studies included reported evidence for negative associa-
tions between substance use (or gambling) and response inhibition
(Tables 1 and 2). In contrast, other studies reported evidence for posi-
tive associations between substance use and inhibition performance in
GNG and SST (significant: Glass et al., 2009; nonsignificant: Galván
et al., 2011; Papachristou et al., 2012b; Vonmoos et al., 2013). In light
of this, it is less surprising that the integrated results indicated overall
largely null findings (most of the confidence intervals ranged around
zero). Similarly, only one out of the five studies included in a recent
review (Carbia et al., 2018) reported impaired response inhibition—as
measured by SST and GNG tasks—in binge drinkers compared with
controls (Czapla et al., 2015).
Fig. 2. The interaction between cannabis and tobacco use on SSRT. Only for
cannabis non-users, the more tobacco a person smoked on a daily basis, the
longer his/her stopping latency. For cannabis users, a mild negative association
was found between tobacco use and SSRT.
2 In the model including interactions with demographics and task-parameters,
tobacco and cannabis use were both positively associated with SSRT. However,
their interaction was not significant, but the three-way interaction with sex was.
Post-hoc tests indicated that, only for male non-cannabis users, tobacco use was
positively associated with SSRT (see in Supplementary Materials S6)
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One explanation is that chronic recreational substance use without a
diagnosis of SUD is not associated with response inhibition impairment.
In other words, a threshold effect rather than a linear effect might exist
between substance use and response inhibition performance.
Alternatively, there might be a linear relationship, albeit shallow and
we only see the effects when comparing very extreme groups (e.g.,
healthy controls vs. SUD in clinical samples). As a result of our exclu-
sion criteria, Fig. S2a and S3a indicate that only a minority of the
participants reached the level of SUD (either reported in individual
paper or categorized based on questionnaire score), and most others
were still within the normal range of use. It is conceivable that in-
hibition is only impaired in SUD (Bjork et al., 2004; Fernández-Serrano
et al., 2011; Noël et al., 2007; Petit et al., 2014). Alternatively, in-
hibition problems may play a role in the transition from heavy use to
SUD. In the SST sample, there were more people diagnosed with to-
bacco dependence (about 10%, Fig. S3a), which might explain why a
positive (although not significant) association of SSRT and tobacco use
was found.
A second possibility is that substance use is actually associated with
impaired inhibition, but we were unable to detect this. Possible reasons
include: sample characteristics (as was discussed in the last paragraph),
the type of tasks included, outcome measures (i.e., effects may only be
visible in biological markers but not in behavior), and statistical power.
Regarding tasks included, there is the possibility that (heavy) use of
psychoactive substances does not lead to a general inhibition problem,
but only to a specific problem in the domain of substance use (hence an
interaction between an appetitive process and suboptimal control,
Jones et al., 2018). A related explanation can be that self-control fail-
ures like maladaptive substance use may reflect a reduced mobilization
of inhibitory control in substance-related contexts rather than generally
impaired inhibitory control competencies (Krönke et al., 2018, 2015;
Wolff et al., 2016). However, in a secondary analysis, we did not find
that substance-related GNG moderated the relationship between al-
cohol and commission error rate (see details in 4.2). Furthermore, the
SST and GNG measure stimulus-driven (exogenous) inhibition, which
may not closely match real-world ‘loss of control’ behavior related to
substance use (e.g., an initial intention to have one drink escalating into
a binge-drinking session, failed suppression of craving, etc). These ex-
amples reflect a different type of inhibition, namely endogenous or
intentional rather than exogenous inhibition. Intentional inhibition
paradigms such as the Marble task (Schel et al., 2014) could be con-
sidered in future research. Regarding outcome measures, it is possible
that biological but not behavioral markers might be more sensitive to
inhibition impairments among substance users (Garrison and Potenza,
2014). Relatedly, some of the included MRI studies reported specific
group-related abnormalities in brain activation but not in behavioral
outcomes (e.g., Claus, Ewing et al., 2013; de Ruiter et al., 2012; Galván
et al., 2011; Karoly, Weiland et al., 2014; Luijten et al., 2013a; Roberts
and Garavan, 2010). In addition, a recent study indicated that resting
state fMRI connectivity might serve as a promising biomarker of alcohol
use disorder severity (Fede et al., 2019; see further, Steele et al., 2019
for additional recent approaches to identifying biormarkers for addic-
tion). Alternatively, Kwako et al. (2018) suggested a dimensional ap-
proach to biomarkers in terms of executive functions (inhibitory con-
trol, working memory, etc.), which includes measuring
neuropsychological tests and epigenetic changes in relevant genes (e.g.,
COMT). With respect to statistical power, polysubstance use was coarsely
defined, such that substances other than alcohol and tobacco had to be
coded in a binary lifetime use variable. It is still possible that (heavy)
use of a specific combinations of substances at the same time (e.g.,
cocaine and alcohol, Schulte et al., 2014) does have a negative impact,
which did not emerge from our analysis here using binary variables. In
addition, the total author response rate was low, which we discuss as a
limitation. Currently, it remains an open question whether substance
use is not associated with a motor inhibition impairment or if we were
incapable of detecting such an impairment.
4.2. Demographics and task parameters
Our results indicate that age is a significant predictor of perfor-
mance. In the GNG-task, the age-related increase in accuracy is most
likely due to the strategic slowing of responses (confirmed by longer go
RTs). In the SST, SSRT increased with age. Education was positively
correlated with inhibition capability in both tasks. There was not a
significant effect of sex on inhibition, nor any interactions between sex
and substance use. In the GNG, higher working memory load, lower no-
go percentages, and a higher number of experimental trials resulted in
more commission errors. These effects are in line with the primary
literature on these tasks and are further discussed in Supplementary
Materials S1. Somewhat surprisingly, we did not obtain an effect of
substance-related GNG on performance measures compared to classical
task versions. This is in line with a recent meta-analysis, where the main
effect of appetitive cues was not observed after correction for publica-
tion bias, and where drinking status (light vs. heavy drinkers) also did
not moderate this effect (Jones et al., 2018). In a small exploratory
analysis, we examined the ×alcohol substance-related task interaction
effect, which was not a significant predictor of commission error rates
in GNG (Supplementary Materials S6). Still, since our conclusion is
based on only 5 out of 23 included studies, future research should ad-
dress this question. In the SST, visual (vs. auditory) stop signals, fewer
number of trials and fixed SSDs (vs. staircase-tracking procedure) in-
duced prolonged SSRT (elaboration in Supplementary Materials S1).
4.3. Implications
Our results showed no relationship between the use of most sub-
stances and impaired response inhibition, except for a relationship
between cannabis use and impaired inhibition, and in non-cannabis
users an association between cigarette use and impaired inhibition.
What are the theoretical implications? First, these findings could be of
relevance for the current debate on the question whether addiction
should be considered a chronic brain disease or not (Heather et al.,
2017; Leshner, 1997; Lewis, 2015; Volkow et al., 2015). The current
findings do not support the idea that long-term recreational substance
use leads to irreparable problems in inhibition, although it cannot be
excluded that inhibition problems are present in (a subgroup of) people
diagnosed with SUD. Second, in many dual process models of addiction,
suboptimal inhibition of stimulus-driven appetitive processes (cue-re-
activity) plays an important role in the escalation of use (e.g., Baler and
Volkow, 2006; Wiers et al., 2007). An alternative perspective does not
emphasize the competition between stimulus-driven and goal-directed
processes, but rather between different goal-directed processes (Moors
et al., 2017). Individuals learn to mobilize and allocate resources stra-
tegically according to goal saliency and importance (Köpetz et al.,
2013). In this way, the inhibition capability of substance users is ex-
pected to fluctuate moment-to-moment (i.e., state-like) based on the
external and internal context. Note again that the current findings do
not exclude the possibility that in severe addiction(s), chronic inhibi-
tion problems of stimulus-driven processes do play a role. It merely
underscores the goal-directed nature of (heavy) substance use. Third,
impaired response inhibition as an immediate consequence of substance
consumption may be more important than general inhibitory impair-
ments in the long term. Compared with long-term (non-dependent)
substance use, acute use is more consistently related to impaired in-
hibitory control that enhances further consumption (Gan et al., 2014).
4.4. Limitations and suggestions for future study
There are several limitations of the current study worth considering.
First, the response rate was rather low. Although more than 100 studies
met our inclusion and exclusion criteria, authors of only 65 studies
provided raw data. The reasons for this include inaccessibility of the
data, data could not be shared due to regulations, and a lack of success
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in contacting the authors. The low response rate is an obstacle en-
countered commonly in mega-analyses (Riley et al., 2010, 2007). We
calculated and compared the effect sizes of studies that were included,
studies that provided data but that were not included, and studies did
not provide data. It was found that these three kinds of studies did not
differ significantly on effect size (Fig. S4, see statistics in Supplementary
Materials S9). In light of this, an open science framework is re-
commended in order to increase the transparency and availability of
data for future research. Despite these obstacles, we received raw data
from 3610 participants, which should provide sufficient power to test
effects on inhibition of substance use. Second, and relatedly, we noticed
that the original studies did not score the use of every substance, for
example, data on opiates were scarce. Although we tried to remedy this
by means of multiple imputations, the analyses on the effects of these
substances might have been underpowered. Third, except for alcohol
and tobacco use, other substances could only be coded as a binary
‘lifetime use’ variable. It would be optimal if a standard way of asses-
sing all substances could be used in the future when assessing the re-
lationship between substance use and inhibition (or other neu-
ropsychological functions). Guidelines for experimental protocols and
assessment of substance use would facilitate future multicenter com-
parisons, which could be stimulated by funding agencies requiring a
standard assessment of all commonly used substances in a uniform
format. Fourth, studies did not focus on poly-substance use. Studies
recruited individuals taking one substance and recorded one/several
other substances. Therefore, the samples are highly selective and not
representative of poly-substance users. In addition, future studies are
suggested to include a standard index of trait impulsivity (e.g., Ey-
senck’s personality inventory, Eysenck and Eysenck, 1965; BIS-11,
Patton et al., 1995) as it is possible that within-sample variability on
this dimension is obscuring common effects of drug exposure, or has
stand-alone effects, especially for stimulant users (Ersche et al., 2012).
Last, the effects of age and education years should be considered in the
analysis and explanation of results. Task characteristics like stop trial
percentage that consistently influence task performance should also be
considered when comparing across studies.
5. Conclusions
The current mega-analysis aggregated raw data from 3610 partici-
pants in 43 studies on long-term (mostly) light to moderate substance
use and response inhibition. The main finding is that limited evidence
was found for impaired response inhibition in substance users, with two
exceptions: lifetime cannabis use, and cigarette smoking in people who
do not use cannabis. The validity of these findings is underscored by
expected findings for demographics (e.g., age, education level) and task
characteristics (e.g., stop percentage). Broad assessment, standardized
recording and reporting of substance use are highly needed in future
studies.3
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